Cytyc Corp. files registration statement for initial public offering.MARLBOROUGH, Mass.--(BUSINESS WIRE)--Jan. 16, 1996--Cytyc Corp. (Cytyc or the company; proposed NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on NMS See NetWare Management System. symbol: CYTC) announced today that it has filed a registration statement with the Securities and Exchange Commission for an initial public offering of 3,000,000 shares of common stock. The offering price is expected to be between $14 and $16 per share. All of the shares are being sold by Cytyc Corp. The offering will be managed by Robertson, Stephens & Co. LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control and Montgomery Securities. The net proceeds Net Proceeds The amount received after all costs are deducted from the sale of a piece of property or security. Notes: In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions). to the company from the offering will be used to expand marketing and sales efforts, increase manufacturing capacity, fund research and development activities, with the remainder to be used for working capital and other general corporate purposes. Cytyc designs, develops, manufactures and markets a sample preparation system for medical diagnostic applications. The company's ThinPrep System is designed for the automated preparation of microscope slides of cervical cell specimens used in Pap smear Pap smear or Papanicolaou smear Sample of cells from the vagina and cervix of the uterus for laboratory staining and examination to detect genital herpes and early-stage cancer, especially of the cervix. Developed by the Greek-born U.S. testing, as well as slides of non-gynecological cell specimens. The company's pre-market approval application to obtain marketing approval of the ThinPrep System for cervical cancer screening was accepted for filing by the United States Food and Drug Administration United States Food and Drug Administration (FDA), n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics. as of Nov. 22, 1995. The company has marketed the ThinPrep System for use in non-gynecological testing applications since 1991. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. Copies of the preliminary prospectus relating to the offering may be obtained from Robertson, Stephens & Co. LLC, 555 California Street, Suite 2600, San Francisco, Calif. 94104, 415/781-9700; or Montgomery Securities, 600 Montgomery Street, San Francisco, Calif. 94111, 415/627-2000. CONTACT: Cytyc Corp. Patrick J. Sullivan, 508/481-1341 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion